image
Healthcare - Biotechnology - NASDAQ - US
$ 19.12
-4.3 %
$ 2.4 B
Market Cap
-11.95
P/E
INCOME STATEMENT
781 M REVENUE
97.02%
-165 M OPERATING INCOME
68.10%
-198 M NET INCOME
62.57%
EFFICIENCY
Earnings Waterfall Apellis Pharmaceuticals, Inc.
image
Revenue 781 M
Cost Of Revenue 118 M
Gross Profit 664 M
Operating Expenses 829 M
Operating Income -165 M
Other Expenses 32.9 M
Net Income -198 M
800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)(200m)(200m)781m(118m)664m(829m)(165m)(33m)(198m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 781.4 396.6 75.4 66.6 250.6 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 117.7 58.5 5.6 5.2 25.1 288.0 127.9 50.8 0 0 0 0
Gross Profit 663.6 338.1 69.8 61.4 225.6 (288.0) (127.9) (50.8) 0 0 0 0
OPERATING INCOME
Operating Expenses 828.6 855.2 664.4 597.6 439.3 288.0 127.9 50.8 27.3 20.1 11.3 4.0
Selling, General and Administrative Expenses 501.1 500.8 277.2 176.8 139.4 67.0 22.6 10.5 4.3 6.4 2.9 1.7
Research and Development Expenses 327.6 354.4 387.2 420.9 299.9 221.0 105.3 40.3 23.0 13.7 8.4 2.3
Operating Income (165.0) (517.1) (594.6) (536.3) (213.7) (288.0) (127.9) (50.8) (27.3) (46.6) (11.3) (4.0)
PRE-TAX INCOME
Interest Income Expense 40.4 29.6 32.6 13.2 29.9 5.3 2.5 96.9 K 0 0 0 0
Total Other Income (31.7) (9.4) (56.9) (209.7) (129.3) (16.7) 0.4 (0.2) 0.2 57.1 K 62.5 K 68 K
Pre-Tax Income (196.7) (526.5) (651.5) (746.0) (343.0) (304.7) (127.5) (51.0) (27.1) (46.5) (11.2) (4.0)
NET INCOME
Tax Provision 1.2 2.1 0.7 0.4 1.8 5.1 (0.5) 0.3 (27.3) (26.5) (0.4) 0
Net Income (197.9) (528.6) (652.2) (746.4) (344.9) (309.8) (127.5) (51.0) (27.1) (46.5) (10.8) (4.0)
EPS 1.6 4.45 6.15 8.84 4.59 4.98 2.34 3.68 1.5 2.57 0.6 0.22